Megakaryon
Kyoto, JP · 8 known investors
Find your way into Megakaryon
Megakaryon is a regenerative medicine company that develops cell therapies, including iPS cell-derived products such as platelets, for clinical applications. The company operates through collaborative research partnerships with academic institutions and pharmaceutical manufacturers in Japan and internationally.
Investors · 8
Miyako Capital✓ verifiedKyoto
DBJ Capital✓ verifiedTokyo · $2.7M – $354M
Japan Asia Investment✓ verifiedTokyo · $1M – $10M
KSP, Inc.✓ verifiedKawasaki
Mitsubishi UFJ Capital✓ verifiedTokyo · $952K – $269M
Mizuho Capital✓ verifiedTokyo · $1.5M – $340M
Nissay Capital✓ verifiedTokyo · $610K – $71M
SMBC Venture Capital✓ verifiedTokyo · $2.3M – $269M
Frequently asked questions
- What does Megakaryon do?
- Megakaryon is a regenerative medicine company that develops cell therapies, including iPS cell-derived products such as platelets, for clinical applications. The company operates through collaborative research partnerships with academic institutions and pharmaceutical manufacturers in Japan and internationally.
- Who are Megakaryon's investors?
- Megakaryon's investors include Miyako Capital, DBJ Capital, Japan Asia Investment, KSP, Inc., Mitsubishi UFJ Capital, Mizuho Capital, Nissay Capital, SMBC Venture Capital.
- Where is Megakaryon headquartered?
- Megakaryon is headquartered in Kyoto, JP.